1,13 $
4,63 % gestern
Nasdaq, 21. November, 22:00 Uhr
ISIN
IL0011050551
Symbol
EVGN
Berichte

Evogene Ltd Aktie News

Neutral
Seeking Alpha
etwa 21 Stunden alt
EverGen Infrastructure Corp. ( EVGN:CA ) Q3 2025 Earnings Call November 21, 2025 11:00 AM EST Company Participants Chase Edgelow - CEO & Director Maria O'Sullivan - Interim Chief Financial Officer Presentation Operator Welcome to the EverGen Infrastructure Third Quarter 2025 earnings results presentation. [Operator Instructions] As a reminder, this call is being recorded.
Neutral
Seeking Alpha
2 Tage alt
Evogene Ltd. ( EVGN ) Q3 2025 Earnings Call November 20, 2025 9:00 AM EST Company Participants Ofer Haviv - CEO, President & Director Yaron Eldad - Chief Financial Officer Presentation Operator Welcome to Evogene's Third Quarter 2025 Results Conference Call.
Neutral
PRNewsWire
2 Tage alt
Conference call and webcast: today, November 20, 2025, 9:00 AM ET Financial Highlights: During the first nine months ending September 30, 2025, Evogene advanced its strategic transition toward establishing itself as a leader in computational chemistry, with a focus on the generative design of small molecules for the pharmaceutical and agricultural industries. As part of this new strategy, the c...
Neutral
PRNewsWire
11 Tage alt
Collaboration focuses on integrating high-yield castor varieties with advanced mechanized solutions, including harvesting and threshing technologies REHOVOT, Israel and MANTOVA, Italy , Nov. 11, 2025 /PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an Israeli developer of high-yield castor seed varieties and integrated castor farming solutions — and a subsidiary of Evogene Ltd.
Neutral
PRNewsWire
16 Tage alt
Zoom conference call scheduled for November 20, 2025, 9:00 AM ET REHOVOT, Israel , Nov. 6, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the third quarter of 2...
Neutral
PRNewsWire
3 Monate alt
REHOVOT, Israel , Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology and chemistry company, today announced that Ofer Haviv, Evogene's President and CEO, will present at the H.C.
Neutral
Seeking Alpha
3 Monate alt
Evogene Ltd. (NASDAQ:EVGN ) Q2 2025 Earnings Conference Call August 19, 2025 9:00 AM ET Company Participants Ofer Haviv - CEO, President & Director Yaron Eldad - Chief Financial Officer Unidentified Company Representative Welcome to Evogene's Second Quarter 2025 Results Conference Call.
Neutral
PRNewsWire
3 Monate alt
Conference call and webcast: today, August 19, 2025, 9:00 am ET Financial Highlights: The financial results for the first half of 2025 of Lavie Bio, a subsidiary of Evogene and the MicroBoost AI for Ag operations, are presented as a single-line item in Evogene's consolidated statements of profit and loss for the first half of 2025. Their results are included under the line titled - "Loss from o...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen